Civic Intelligence

Aim at Melanoma

990 • Fiscal year 2022 • EIN 56-2427805

Jan 01, 2022 to Dec 31, 2022 • Filed on Feb 09, 2024

Organization ProfileWWW.AIMATMELANOMA.ORG

View Organization Page

3040 Cutting BlvdRichmond, CA 94804

(916) 706-0599

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

12th percentile

0.00x

Higher debt load relative to assets than 12% of similar nonprofits.

2022 filings • 501(c)3 • $5M-$10M nonprofits • Source year 2022

Liabilities / Revenue

10th percentile

0.00x

Higher debt load relative to revenue than 10% of similar nonprofits.

2022 filings • 501(c)3 • $5M-$10M nonprofits • Source year 2022

Net Margin

64th percentile

15%

Higher net margin than 64% of similar nonprofits.

2022 filings • 501(c)3 • $5M-$10M nonprofits • Source year 2022

Top Officer Pay

78th percentile

$209,963

Higher top officer pay than 78% of similar nonprofits.

Top officer pay equals 8.1% of source-year revenue.

2022 filings • 501(c)3 • $5M-$10M nonprofits • Source year 2022

Asset Growth

67th percentile

8.4%

Faster asset growth than 67% of similar nonprofits.

2022 filings • 501(c)3 • $5M-$10M nonprofits • Annualized from 2021 to 2022

Revenue Growth

26th percentile

-11%

Faster revenue growth than 26% of similar nonprofits.

2022 filings • 501(c)3 • $5M-$10M nonprofits • Annualized from 2021 to 2022

Balance Sheet
Liabilities / Assets12th percentile

Assets

Up

$5,081,407

Up $393,258 (+8.4%) from 2021

Net Assets

Up

$5,073,387

Up $391,573 (+8.4%) from 2021

Liabilities

Up

$8,020

Up $1,685 (+27%) from 2021

Revenue And Expenses
Liabilities / Revenue10th percentileNet Margin64th percentile

Revenue

Down

$2,586,311

Down $314,946 (-11%) from 2021

Expenses

Up

$2,194,738

Up $352,540 (+19%) from 2021

Net Income

Down

$391,573

Down $667,486 (-63%) from 2021

Historical Trend

Balance Sheet Trend

Asset Growth67th percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$8.0M$6.0M$4.0M$2.0M$0Assets 2010: $461,059Liabilities 2010: $2,479Net Assets 2010: $458,5802010Assets 2011: $835,775Liabilities 2011: $2,558Net Assets 2011: $833,2172011Assets 2012: $1,120,456Liabilities 2012: $0Net Assets 2012: $1,120,4562012Assets 2013: $1,182,080Liabilities 2013: $0Net Assets 2013: $1,182,0802013Assets 2014: $1,299,576Liabilities 2014: $0Net Assets 2014: $1,299,5762014Assets 2015: $1,680,474Liabilities 2015: $0Net Assets 2015: $1,680,4742015Assets 2016: $2,054,940Liabilities 2016: $0Net Assets 2016: $2,054,9402016Assets 2017: $2,398,753Liabilities 2017: $0Net Assets 2017: $2,398,7532017Assets 2018: $2,573,532Liabilities 2018: $0Net Assets 2018: $2,573,5322018Assets 2019: $3,228,161Liabilities 2019: $121,577Net Assets 2019: $3,106,5842019Assets 2020: $3,672,755Liabilities 2020: $50,000Net Assets 2020: $3,622,7552020Assets 2021: $4,688,149Liabilities 2021: $6,335Net Assets 2021: $4,681,8142021Assets 2022: $5,081,407Liabilities 2022: $8,020Net Assets 2022: $5,073,3872022Assets 2023: $6,023,375Liabilities 2023: $17,955Net Assets 2023: $6,005,4202023Assets 2024: $6,666,866Liabilities 2024: $19,708Net Assets 2024: $6,647,1582024

Highlighted filing

2022

Assets$5,081,407
Liabilities$8,020
Net Assets$5,073,387
Open 2022 Filing

Operations Trend

Revenue Growth26th percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$4.0M$3.0M$2.0M$1.0M$0Expenses 2010: $746,3772010Expenses 2011: $871,4672011Expenses 2012: $865,7082012Revenue 2013: $1,242,832Expenses 2013: $1,181,208Net Income 2013: $61,6242013Revenue 2014: $1,322,017Expenses 2014: $1,204,521Net Income 2014: $117,4962014Revenue 2015: $1,650,655Expenses 2015: $1,269,757Net Income 2015: $380,8982015Revenue 2016: $1,782,881Expenses 2016: $1,408,415Net Income 2016: $374,4662016Revenue 2017: $2,415,270Expenses 2017: $2,071,457Net Income 2017: $343,8132017Revenue 2018: $2,544,308Expenses 2018: $2,369,528Net Income 2018: $174,7802018Revenue 2019: $2,571,648Expenses 2019: $2,037,762Net Income 2019: $533,8862019Revenue 2020: $2,335,060Expenses 2020: $1,818,889Net Income 2020: $516,1712020Revenue 2021: $2,901,257Expenses 2021: $1,842,198Net Income 2021: $1,059,0592021Revenue 2022: $2,586,311Expenses 2022: $2,194,738Net Income 2022: $391,5732022Revenue 2023: $3,245,381Expenses 2023: $2,313,348Net Income 2023: $932,0332023Revenue 2024: $2,971,089Expenses 2024: $2,329,351Net Income 2024: $641,7382024

Highlighted filing

2022

Revenue$2,586,311
Expenses$2,194,738
Net Income$391,573
Open 2022 Filing
Jump To
Filing Snapshot
Filing Period
Jan 1, 2022 to Dec 31, 2022
Signed
Feb 9, 2024
Return Version
2022v5.0
Gross Receipts
$3,699,681
Mission and Program Overview

Mission

AIM at Melanoma is globally engaged and locally invested in advancing the battle against melanoma through innovative research, legislative reform, education, and patient and caregiver support.The AIM at Melanoma website (www.aimatmelanoma.org) is the world's largest most comprehensive melanoma website for patients/caregivers/families. This website is viewed by 40,000 unique users per month in the US, Canada, Australia, and Europe. It serves to educate people around the globe about prevention, early detection, melanoma diagnosis, available treatments, and clinical trials.

To support melanoma research; to promote prevention and education among the general public and medical professionals; and to provide comprehensive and easily accessible melanoma resources for patients, survivors, and caregivers.

Balance Sheet Detail
LineBeginningEndChange
Assets
Rtn Earn Endowment Incm Other Fnds$4,681,814$5,073,387▲ $391,573
Savings and Temporary Cash Investments$3,815,883$4,277,158▲ $461,275
Cash and Non-Interest-Bearing Accounts$851,490$784,907▼ $66,583
Land, Buildings, and Equipment, Net$20,776$17,825▼ $2,951
Prepaid Expenses and Deferred Charges-$1,517-
Pd in Cap Srpls Land Bldg Eqp Fund$0$0→ $0
Cap Stk Tr Prin Current Funds$0$0→ $0
Total Assets$4,688,149$5,081,407▲ $393,258
Liabilities
Other Liabilities$6,335$8,020▲ $1,685
Total Liabilities$6,335$8,020▲ $1,685
Net Assets / Fund Balance
Total Net Assets Fund Balance$4,681,814$5,073,387▲ $391,573
Total Liabilities and Net Assets / Fund Balance$4,688,149$5,081,407▲ $393,258

Asset Categories

AssetBook ValueDepreciationBasis
Other Land Buildings$17,825$65,066$82,891
Compensation and Service Providers
Top Officer Pay78th percentile

Employees

NameTitleFull / Part TimeBaseOtherTotal
Samantha GuildPresident and DirectorFT$162,000$47,963$209,963
Alicia RowellVice PresidentFT$160,008-$160,008

Board Members and Trustees

NameTitle
Howard MaibachDirector
John KirkwoodDirector
Mohammed Kashani-sabetDirector
Renu GuptaDirector
Revenue and Support

Revenue Composition

Contributions and Grants
$2,571,483
Program Service Revenue
$9,500
Investment Income
$5,328
Other Revenue
$0
All Other Contributions
$2,229,115
Change in Net Assets
$391,573

Audited Revenue Reconciliation

Revenue per Audited Statements
$2,571,483
Revenue Not Reported on Financial Statements
$14,828
Revenue Not Reported on Form 990
$0
Other Revenue Adjustments
$14,828
Total Revenue per Audited Statements
$2,571,483
Total Revenue per Form 990
$2,586,311
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Other Expenses$1,130,816
Salaries, Compensation, and Employee Benefits$815,922
Grants and Similar Amounts Paid$248,000
Total Fundraising Expense$67,588
Professional Fundraising Fees$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Current Officers, Directors, Trustees, and Key Employees$321,657$9,350$16,001$347,008
Other Salaries and Wages$288,242$16,955$33,911$339,108
Grants to Domestic Orgs$248,000--$248,000
All Other Expenses$139,898-$8,386$148,284
Other Employee Benefits$69,150$3,933$5,569$78,652
Office Expenses$13,000$43,156-$56,156
Other Expenses$52,986--$52,986
Payroll Taxes$45,472$1,961$3,721$51,154
Occupancy-$37,905-$37,905
Fees for Services Accounting-$26,645-$26,645
Insurance$17,930--$17,930
Depreciation Depletion-$6,446-$6,446
Advertising$4,543--$4,543
Total Functional Expenses$1,980,799$146,351$67,588$2,194,738

Audited Expense Reconciliation

Line ItemAmount
Expenses per Audited Statements$2,194,738
Total Expenses per Audited Statements$2,194,738
Total Expenses per Form 990$2,194,738
Expenses Not Reported on Financial Statements$0
Expenses Not Reported on Form 990$0
International Activity

Grant and Assistance Recipients

RecipientLocationCategoryPurposeAmount
Mtbc Melanoma Tissue Bank ConsortiumSacramento, CA-Tissue Bank$200,000
Upmc Univ of Pittsburgh Cancer InstitutePittsburgh, PA-Cancer and Melanoma Research$38,000
Ohsu Knight Cancer InstitutePortland, OR-Cancer and Melanoma Research$10,000
Fundraising, Events, and Gaming
Fundraising activities
Yes
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Fundraising Direct Expenses$85,756
Fundraising Gross Income$85,756
Professional Fundraising Fees$0

Fundraising Events

EventGross ReceiptsGross RevenueDirect ExpensesNet Income
AIM FOR THE "CURE MELANOMA WALKS"$342,368$342,368-$342,368
Total Events$342,368$342,368-$342,368
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Debt and Bond Financing

Other Reported Liabilities

LiabilityAmount
Insurance Payable$5,058
Pension Payable$2,962
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Audit committee
Yes
Backup withholding compliance
Yes
Business relationship with 35% controlled entity
No
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
No
Other officer compensation reviewed
No
Conflict-of-interest policy
Yes
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section B, Line 11B

“Form 990 is submitted by the accountant to the governing body for review and discussion. The president approves the filing of form 990 based on compliance and accuracy. The accountant is then given authorization to file.”

Form 990, Part VI, Section C, Line 19

“All governing documents, conflict of interest policy and applicable financial statements are available to the public upon request”

Filing and Contact Details

Filer

Filer Name
Aim at Melanoma
EIN
56-2427805
Phone
9167060599
Address
3040 CUTTING BLVD, RICHMOND, CA 94804

Signing Officer

Name
Samantha Guild
Title
President
Phone
9167060599
Signed
2024-02-09
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Samantha Guild
Formed
2004
Legal Domicile
CA
Voting Board Members
5
Independent Board Members
4
Employees
9
Volunteers
0

Preparer

Firm
Charles M Moche CPA
Address
2050 CENTER AVENUE SUITE 435, FORT LEE, NJ 07024
Preparer
Charles M Moche
Phone
2014651800
Supplemental Narrative

Additional Explanations

Form 990 Part XII Line 2C

“A committee assumes responsibility for the oversight of the audit, review or compilation of its financial statements and selection of its independent auditors. The organization did not change its oversight or selection process during the tax year.”

Form 990 Page 12 Part XII Boxes 2B and 2C

“The organization's financial statements are audited by an independent accountant. The original filing did not indicate this correctly on form 990 page 12 part xii boxes 2b and 2c. In this amended filing, boxes 2b and 2c are now accurately marked "yes".”

Financial Statement Notes

PART XI, LINE 4B - OTHER ADJUSTMENTS:

“Investment income 5,328. Consulting and honorarium 9,500.”

Raw XML AppendixShowing 400 of 497 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd00
IRS990/ActivitiesConductedPrtshpInd00
IRS990/ActivityOrMissionDesc0TO SUPPORT MELANOMA RESEARCH; TO PROMOTE PREVENTION AND EDUCATION AMONG THE GENERAL PUBLIC AND MEDICAL PROFESSIONALS; AND TO PROVIDE COMPREHENSIVE AND EASILY ACCESSIBLE MELANOMA RESOURCES FOR PATIENTS, SURVIVORS, AND CAREGIVERS.
IRS990/AdvertisingGrp/ProgramServicesAmt04543
IRS990/AdvertisingGrp/TotalAmt04543
IRS990/AllOtherContributionsAmt02229115
IRS990/AllOtherExpensesGrp/FundraisingAmt08386
IRS990/AllOtherExpensesGrp/ProgramServicesAmt0139898
IRS990/AllOtherExpensesGrp/TotalAmt0148284
IRS990/AmendedReturnInd0X
IRS990/AnnualDisclosureCoveredPrsnInd01
IRS990/AuditCommitteeInd01
IRS990/BackupWthldComplianceInd01
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0THE ORGANIZATION
IRS990/BooksInCareOfDetail/PhoneNum09167060599
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt03040 CUTTING BLVD
IRS990/BooksInCareOfDetail/USAddress/CityNm0RICHMOND
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0CA
IRS990/BooksInCareOfDetail/USAddress/ZIPCd094804
IRS990/BusinessRlnWith35CtrlEntInd00
IRS990/BusinessRlnWithFamMemInd00
IRS990/BusinessRlnWithOrgMemInd00
IRS990/CapStkTrPrinCurrentFundsGrp/BOYAmt00
IRS990/CapStkTrPrinCurrentFundsGrp/EOYAmt00
IRS990/CashNonInterestBearingGrp/BOYAmt0851490
IRS990/CashNonInterestBearingGrp/EOYAmt0784907
IRS990/ChangeToOrgDocumentsInd00
IRS990/CntrctRcvdGreaterThan100KCnt00
IRS990/CollectionsOfArtInd00
IRS990/CompCurrentOfcrDirectorsGrp/FundraisingAmt016001
IRS990/CompCurrentOfcrDirectorsGrp/ManagementAndGeneralAmt09350
IRS990/CompCurrentOfcrDirectorsGrp/ProgramServicesAmt0321657
IRS990/CompCurrentOfcrDirectorsGrp/TotalAmt0347008
IRS990/CompensationFromOtherSrcsInd00
IRS990/CompensationProcessCEOInd00
IRS990/CompensationProcessOtherInd00
IRS990/ConflictOfInterestPolicyInd01
IRS990/ConservationEasementsInd00
IRS990/ConsolidatedAuditFinclStmtInd00
IRS990/ContriRptFundraisingEventAmt0342368
IRS990/CreditCounselingInd00
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt02571483
IRS990/CYGrantsAndSimilarPaidAmt0248000
IRS990/CYInvestmentIncomeAmt05328
IRS990/CYOtherExpensesAmt01130816
IRS990/CYOtherRevenueAmt00
IRS990/CYProgramServiceRevenueAmt09500
IRS990/CYRevenuesLessExpensesAmt0391573
IRS990/CYSalariesCompEmpBnftPaidAmt0815922
IRS990/CYTotalExpensesAmt02194738
IRS990/CYTotalFundraisingExpenseAmt067588
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt02586311
IRS990/DecisionsSubjectToApprovaInd00
IRS990/DeductibleArtContributionInd00
IRS990/DeductibleNonCashContriInd00
IRS990/DelegationOfMgmtDutiesInd00
IRS990/DepreciationDepletionGrp/ManagementAndGeneralAmt06446
IRS990/DepreciationDepletionGrp/TotalAmt06446
IRS990/Desc0WEBSITEAIM AT MELANOMA ("AIM") IS AN INTERNATIONAL ORGANIZATION ENGAGED IN A WIDE VARIETY OF PATIENT ADVOCACY INITIATIVES. AMONG THESE IS THE MAINTENANCE OF THE MOST COMPREHENSIVE U.S. WEBSITE ON MELANOMA (WWW.AIMATMELANOMA.ORG). IN 2022, AIM CONTINUED TO ADD MORE CONTENT SO IT WOULD BETTER BE ABLE TO MEET THE NEEDS OF THE MELANOMA COMMUNITY. THIS INCLUDED MAKING IT EASIER FOR USERS TO LOCATE PERTINENT INFORMATION TO ASSIST THEM IN BETTER UNDERSTANDING THEIR MELANOMA DIAGNOSIS, RISK OF RECURRENCE, DETERMINING THEIR TREATMENT OPTIONS, MANAGE THE SIDE EFFECTS OF TREATMENT, UNDERSTANDING FOLLOW-UP CARE AND ADDRESS THE PSYCHOSOCIAL ASPECTS OF THE DISEASE. THE ORGANIZATION CONTINUED TO USE VARIOUS TOOLS SUCH AS SEARCH ENGINE OPTIMIZATION AND DISTRIBUTING BROCHURES TO HEALTHCARE PROVIDERS THROUGHOUT THE U.S. TO EDUCATE MELANOMA PATIENTS ABOUT THE WEBSITE'S RESOURCES. THE WEBSITE WAS ALSO UPDATED REGULARLY FOR MEDICAL ACCURACY IN ORDER TO REFLECT THE CURRENT STANDARD OF CARE IN MELANOMA AND WITH CONTENT RELATED TO ISSUES FACING THE MELANOMA COMMUNITY. THE U.S. WEBSITE ALONE, HAD MORE THAN 65,000 UNIQUE VISITORS EACH MONTH.PATIENT ADVOCACYAIM CONTINUED TO PROVIDE A FREE PHYSICIAN ASSISTANT ON CALL SERVICE. THROUGHOUT THE YEAR, MELANOMA PATIENTS, CAREGIVERS, AND FAMILIES REACHED OUT TO AIM'S ONCOLOGY PHYSICIAN ASSISTANT TO ASK QUESTIONS ABOUT, AMONG OTHER THINGS, THEIR/OR THEIR LOVED ONE'S MELANOMA DIAGNOSIS, TREATMENT OPTIONS, CLINICAL TRIALS, AND FOLLOW-UP CARE AS WELL AS QUESTIONS REGARDING PREVENTION AND EARLY DETECTION OF THE DISEASE. AIM ALSO COORDINATED NUMEROUS PATIENT ADVOCACY EVENTS, WHICH INCLUDED 10 PATIENT AND CAREGIVER SYMPOSIA LED BY NATIONALLY RECOGNIZED MELANOMA ONCOLOGISTS AT MAJOR CANCER CENTERS SUCH AS MD ANDERSON CANCER CENTER, UNIVERSITY OF MICHIGAN HEALTH SYSTEMS, NYU LANGONE PERMUTTER CANCER CENTER, UNIVERSITY OF COLORADO CANCER CENTER FOR RARE MELANOMAS, AND MOFFITT CANCER CENTER. THE SYMPOSIA BEGAN TO RETURN TO IN-PERSON EVENTS. ATTENDEES ALSO LIVE STREAMED GLOBALLY. AIM ALSO VIDEOTAPED AND EDITED THESE SYMPOSIUMS, WHICH WERE THEN UPLOADED ONTO YOUTUBE AND AIM'S WEBSITE SO THAT THEY COULD BE VIEWED BY INDIVIDUALS IN THE U.S. AND WORLDWIDE. AIM CONTINUED TO PROVIDE SUPPORT FOR PATIENTS, FAMILIES, AND SURVIVORS THROUGH A PROGRAM CALLED PEER CONNECT. PEER CONNECT IS A PEER-TO-PEER SUPPORT PROGRAM, AIM AT MELANOMA'S ANSWER TO THE ONGOING NEED FOR SUPPORT IN THE MELANOMA COMMUNITY. MELANOMA PATIENTS, FAMILY MEMBERS, AND CAREGIVERS WHO JOIN THE PROGRAM ARE MATCHED WITH A PEER, AND FROM THERE THE PAIR COMMUNICATE IN A WAY THAT IS COMFORTABLE FOR BOTH. MEMBERS OF PEER CONNECT PROVIDE EACH OTHER WITH KNOWLEDGE, EXPERIENCE, EMOTIONAL SUPPORT, AND MORE.AIM MAINTAINED A FACEBOOK PAGE, WHICH NOW HAS OVER 25,500 FOLLOWERS, A TWITTER ACCOUNT OF OVER 7,800 FOLLOWERS AND AN INSTAGRAM ACCOUNT OF OVER 2,800 FOLLOWERS IN ORDER TO PROVIDE OTHER SOURCES OF INFORMATION FOR THE MELANOMA COMMUNITY.AIM CONTINUED TO REPRESENT PATIENTS ON THE TWO LARGEST U.S. COOPERATIVE ONCOLOGY GROUPS, SWOG AND ECOG, THE NCCN, AND THE ASCO GUIDELINES COMMITTEE. AIM ALSO PRESENTED ON THE MELANOMA PATIENT PERSPECTIVE AT NUMEROUS MEETINGS BOTH IN THE U.S. AND THROUGHOUT THE WORLD, WHICH RETURNED TO IN-PERSON FORMAT IN 2022. TO HELP PATIENTS UNDERSTAND THEIR DISEASE, AIM CONTINUED TO OFFER FROM THE CLINIC TO THE LIVING ROOM, A WEBINAR SERIES THAT IS LIVE STREAMED THROUGH FACEBOOK TO PROVIDE AN IN-DEPTH DISCUSSION ON A SPECIFIC TOPIC WITH A MELANOMA SPECIALIST, SUCH AS A PHYSICIAN, RESEARCHER, OR OTHER MEDICAL EXPERT. AIM ALSO CONTINUED TO OFFER BEYOND THE CLINIC: LIVING WELL WITH MELANOMA, A PODCAST SERIES TO ADDRESS THE PSYCHOSOCIAL ASPECTS OF A MELANOMA DIAGNOSIS DURING AND BEYOND TREATMENT. AIM ALSO CONTINUED TO OFFER MELANOMA360 BLOG, WHICH FEATURES SURVIVOR STORIES, RESEARCH BREAKTHROUGHS, CURRENT NEWS, HEALTH LIVING INFORMATION ETC.GLOBAL ADVOCACYAIM'S PATIENT ADVOCACY IS A GLOBAL EFFORT. IN 2022, AIM CONTINUED TO SUPPORT AND MENTOR PATIENT ADVOCACY
IRS990/DescribedInSection501c3Ind01
IRS990/DisregardedEntityInd00
IRS990/DocumentRetentionPolicyInd01
IRS990/DonorAdvisedFundInd00
IRS990/DonorRstrOrQuasiEndowmentsInd00
IRS990/ElectionOfBoardMembersInd00
IRS990/EmployeeCnt09
IRS990/EmploymentTaxReturnsFiledInd01
IRS990/EngagedInExcessBenefitTransInd00
IRS990/ExpenseAmt01980799
IRS990/FamilyOrBusinessRlnInd00
IRS990/FederalGrantAuditRequiredInd00
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt026645
IRS990/FeesForServicesAccountingGrp/TotalAmt026645
IRS990/ForeignActivitiesInd00
IRS990/ForeignFinancialAccountInd00
IRS990/ForeignOfficeInd00
IRS990/Form8282PropertyDisposedOfInd00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt03.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt13.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt21.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt31.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt460.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt540.00
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt422963
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt50
IRS990/Form990PartVIISectionAGrp/PersonNm0JOHN KIRKWOOD
IRS990/Form990PartVIISectionAGrp/PersonNm1MOHAMMED KASHANI-SABET
IRS990/Form990PartVIISectionAGrp/PersonNm2RENU GUPTA
IRS990/Form990PartVIISectionAGrp/PersonNm3HOWARD MAIBACH
IRS990/Form990PartVIISectionAGrp/PersonNm4SAMANTHA GUILD
IRS990/Form990PartVIISectionAGrp/PersonNm5ALICIA ROWELL
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt4187000
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt5160008
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/TitleTxt0DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt1DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt2DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt3DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt4PRESIDENT AND DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt5VICE PRESIDENT
IRS990/Form990ProvidedToGvrnBodyInd01
IRS990/FormationYr02004
IRS990/FormerOfcrEmployeesListedInd00
IRS990/FSAuditedBasisGrp/SeparateBasisFinclStmtInd0X
IRS990/FSAuditedInd01
IRS990/FundraisingActivitiesInd01
IRS990/FundraisingAmt0342368
IRS990/FundraisingDirectExpensesAmt085756
IRS990/FundraisingGrossIncomeAmt085756
IRS990/GainOrLossGrp/SecuritiesAmt0-15011
IRS990/GamingActivitiesInd00
IRS990/GoverningBodyVotingMembersCnt05
IRS990/GrantAmt0248000
IRS990/GrantsToDomesticOrgsGrp/ProgramServicesAmt0248000
IRS990/GrantsToDomesticOrgsGrp/TotalAmt0248000
IRS990/GrantsToIndividualsInd00
IRS990/GrantsToOrganizationsInd01
IRS990/GrantToRelatedPersonInd00
IRS990/GrossAmountSalesAssetsGrp/SecuritiesAmt01012603
IRS990/GrossReceiptsAmt03699681
IRS990/GroupReturnForAffiliatesInd00
IRS990/IncludeFIN48FootnoteInd00
IRS990/IndependentAuditFinclStmtInd01
IRS990/IndependentVotingMemberCnt04
IRS990/IndivRcvdGreaterThan100KCnt02
IRS990/IndoorTanningServicesInd00
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InfoInScheduleOPartXIIInd0X
IRS990/InsuranceGrp/ProgramServicesAmt017930
IRS990/InsuranceGrp/TotalAmt017930
IRS990/InvestmentIncomeGrp/ExclusionAmt020339
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt020339
IRS990/InvestmentInJointVentureInd00
IRS990/IRPDocumentCnt08
IRS990/IRPDocumentW2GCnt00
IRS990/LandBldgEquipAccumDeprecAmt065066
IRS990/LandBldgEquipBasisNetGrp/BOYAmt020776
IRS990/LandBldgEquipBasisNetGrp/EOYAmt017825
IRS990/LandBldgEquipCostOrOtherBssAmt082891
IRS990/LegalDomicileStateCd0CA
IRS990/LessCostOthBasisSalesExpnssGrp/SecuritiesAmt01027614
IRS990/LoanOutstandingInd00
IRS990/LobbyingActivitiesInd00
IRS990/LocalChaptersInd00
IRS990/MaterialDiversionOrMisuseInd00
IRS990/MembersOrStockholdersInd00
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd01
IRS990/MinutesOfGoverningBodyInd01
IRS990/MissionDesc0AIM AT MELANOMA (AIM) IS GLOBALLY ENGAGED AND LOCALLY INVESTED IN ADVANCING THE BATTLE AGAINST MELANOMA THROUGH INNOVATIVE RESEARCH, LEGISLATIVE REFORM, EDUCATION, AND PATIENT AND CAREGIVER SUPPORT. FOUNDED IN 2004, AIM AT MELANOMA IS THE LARGEST INTERNATIONAL MELANOMA FOUNDATION SEEKING THE CURE FOR MELANOMA. AIM BELIEVES THAT THE CURE FOR MELANOMA WILL BE FOUND MORE QUICKLY BY BRINGING TOGETHER LEADING GLOBAL RESEARCHERS AND FUNDING THEIR COLLABORATIVE RESEARCH. OUR THREE PARADIGM-SHIFTING GLOBAL RESEARCH INITIATIVES, INCLUDING THE MELANOMA TISSUE BANK CONSORTIUM, ARE POISED TO RESHAPE THE FUTURE OF MELANOMA. AIM IS THE RESPECTED VOICE OF MELANOMA ACROSS THE NATION. WHEN DRUGS ARE APPROVED, LEGISLATION IS DRAFTED, AND RESEARCH IS ASSESSED, AIM IS AT THE TABLE, SPEAKING LOUDLY AND CLEARLY ON BEHALF OF PATIENTS AND THEIR FAMILIES. AIM IS THE TRUSTED ADVISOR FOR PHARMACEUTICAL COMPANIES, MEDICAL BOARDS, AND GOVERNMENT AGENCIES ON CRITICAL TOPICS THAT AFFECT MELANOMA PATIENTS.
IRS990/MoreThan5000KToIndividualsInd00
IRS990/MoreThan5000KToOrgInd00
IRS990/NetAssetsOrFundBalancesBOYAmt04681814
IRS990/NetAssetsOrFundBalancesEOYAmt05073387
IRS990/NetGainOrLossInvestmentsGrp/ExclusionAmt0-15011
IRS990/NetGainOrLossInvestmentsGrp/TotalRevenueColumnAmt0-15011
IRS990/NetIncmFromFundraisingEvtGrp/TotalRevenueColumnAmt00
IRS990/NetUnrelatedBusTxblIncmAmt00
IRS990/NoncashContributionsAmt0973
IRS990/NondeductibleContributionsInd00
IRS990/OccupancyGrp/ManagementAndGeneralAmt037905
IRS990/OccupancyGrp/TotalAmt037905
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt043156
IRS990/OfficeExpensesGrp/ProgramServicesAmt013000
IRS990/OfficeExpensesGrp/TotalAmt056156
IRS990/OfficerMailingAddressInd00
IRS990/OperateHospitalInd00
IRS990/Organization501c3Ind0X
IRS990/OrgDoesNotFollowFASB117Ind0X
IRS990/OtherChangesInNetAssetsAmt00
IRS990/OtherEmployeeBenefitsGrp/FundraisingAmt05569
IRS990/OtherEmployeeBenefitsGrp/ManagementAndGeneralAmt03933
IRS990/OtherEmployeeBenefitsGrp/ProgramServicesAmt069150
IRS990/OtherEmployeeBenefitsGrp/TotalAmt078652
IRS990/OtherExpensesGrp/Desc0PATIENT EDUCATION AND S
IRS990/OtherExpensesGrp/Desc1PHYSICIAN/NURSE EDUCATI
IRS990/OtherExpensesGrp/Desc2RESEARCH MEETINGS
IRS990/OtherExpensesGrp/Desc3GLOBAL ADVOCACY
IRS990/OtherExpensesGrp/ProgramServicesAmt0355571
IRS990/OtherExpensesGrp/ProgramServicesAmt1297262
IRS990/OtherExpensesGrp/ProgramServicesAmt2127088
IRS990/OtherExpensesGrp/ProgramServicesAmt352986
IRS990/OtherExpensesGrp/TotalAmt0355571
IRS990/OtherExpensesGrp/TotalAmt1297262
IRS990/OtherExpensesGrp/TotalAmt2127088
IRS990/OtherExpensesGrp/TotalAmt352986
IRS990/OtherLiabilitiesGrp/BOYAmt06335
IRS990/OtherLiabilitiesGrp/EOYAmt08020
IRS990/OtherSalariesAndWagesGrp/FundraisingAmt033911
IRS990/OtherSalariesAndWagesGrp/ManagementAndGeneralAmt016955
IRS990/OtherSalariesAndWagesGrp/ProgramServicesAmt0288242
IRS990/OtherSalariesAndWagesGrp/TotalAmt0339108
IRS990/PartialLiquidationInd00
IRS990/PayrollTaxesGrp/FundraisingAmt03721
IRS990/PayrollTaxesGrp/ManagementAndGeneralAmt01961
IRS990/PayrollTaxesGrp/ProgramServicesAmt045472
IRS990/PayrollTaxesGrp/TotalAmt051154
IRS990/PdInCapSrplsLandBldgEqpFundGrp/BOYAmt00
IRS990/PdInCapSrplsLandBldgEqpFundGrp/EOYAmt00
IRS990/PoliticalCampaignActyInd00
IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt01517
IRS990/PrincipalOfficerNm0SAMANTHA GUILD
IRS990/ProfessionalFundraisingInd00
IRS990/ProgramServiceRevenueGrp/BusinessCd0541900
IRS990/ProgramServiceRevenueGrp/BusinessCd1541900
IRS990/ProgramServiceRevenueGrp/Desc0CONSULTING
IRS990/ProgramServiceRevenueGrp/Desc1HONORARIUM
IRS990/ProgramServiceRevenueGrp/RelatedOrExemptFuncIncomeAmt05000
IRS990/ProgramServiceRevenueGrp/RelatedOrExemptFuncIncomeAmt14500
IRS990/ProgramServiceRevenueGrp/TotalRevenueColumnAmt05000
IRS990/ProgramServiceRevenueGrp/TotalRevenueColumnAmt14500
IRS990/ProgSrvcAccomActy2Grp/Desc0CONTINUED FROM SCHEDULE OSEARCHABLE CONTENT ON SUPPORTIVE CARE ASPECTS OF MELANOMA THERAPY (SIDE EFFECT MANAGEMENT AS WELL AS ADHERENCE ISSUES), KEY RESOURCES ON TARGETED THERAPY, IMMUNOTHERAPY, AND INTRALESIONAL IMMUNOTHERAPY ONLINE RESOURCES AS WELL AS PRINT PIECES FOR DISTRIBUTION AT REGIONAL CANCER MEETING.3. CJON (ONS) SUPPLEMENT ON OPTIMIZING OUTCOMES FOR MELANOMA THERAPIES 7-ARTICLE SUPPLEMENT IN CJON TO INCLUDE AN INTRODUCTION BY 2 MELANOMA PHYSICIANS, AN OVERVIEW DOCUMENT FROM OUR CHAIR, AND 5 ARTICLES ON SUPPORT STRATEGIES FOR TARGETED THERAPY, IMMUNOTHERAPY, AND INTRALESIONAL IMMUNOTHERAPY ARTICLES ARE MADE AVAILABLE THROUGH OPEN ACCESS LOCATED ON OUR PORTAL.4. JADPRO SUPPLEMENT ON THE MANAGEMENT OF IMMUNE RELATED ADVERSE EVENTS THIS 4-ARTICLE SUPPLEMENT IN JADPRO COVERS IMMUNO-ONCOLOGY THERAPY ESSENTIALS: PROACTIVE MANAGEMENT OF IMMUNE-RELATED ADVERSE EVENTS. BOTH THE CJON AND JADPRO SUPPLEMENTS ARE AVAILABLE AS WELL ON THE MNI WEBSITE.5. JCO ONCOLOGY PRACTICE ON INTERDISCIPLINARY CARE FOR MANAGEMENT OF COMPLEX IRAES. THE ARTICLES IN THE SUPPLEMENT COVERS IMMUNO-ONCOLOGY APPLICATIONS IN CLINICAL SCENARIOSINTRODUCTION, TOXICITY MANAGEMENT OF FRONT-LINE PEMBROLIZUMAB COMBINED WITH AXITINIB IN CLEAR CELL METASTATIC RENAL CELL CARCINOMA: A CASE STUDY APPROACH, MANAGEMENT OF PNEUMONITIS AND NEUROPATHY IN PATIENTS RECEIVING PD-1BASED THERAPY FOR NONSMALL-CELL LUNG CANCER, THE MANAGEMENT OF IMMUNE-RELATED DERMATITIS AND MUCOSITIS ASSOCIATED WITH PEMBROLIZUMAB IN METASTATIC HUMAN PAPILLOMAVIRUSASSOCIATED SQUAMOUS CELL CARCINOMA OF THE OROPHARYNX, AND ATYPICAL PRESENTATIONS AND MANAGEMENT OF ENDOCRINE AND HEPATIC IMMUNE-RELATED ADVERSE EVENTS FROM ADJUVANT IMMUNE CHECKPOINT INHIBITOR THERAPY IN STAGE III RESECTED MELANOMA. THE JCO SUPPLEMENT ARE AVAILABLE AS WELL ON THE MNI WEBSITE.6. AIM CONTINUED TO PROVIDE AN INTERACTIVE, WEB BASED EDUCATION ON BRAF/MEK INHIBITOR THERAPY FOR MELANOMA TO IMPROVE THE OUTCOMES THROUGH INDISCIPLINARY CARE. THE EDUCATION IS AVAILABLE AS WELL ON THE MNI WEBSITE.7. DEVELOPMENT OF PATIENT RESOURCE MATERIALS CUSTOMIZED PATIENT RESOURCE/EDUCATION MATERIALS (PRINTABLE PDFS) HAVE BEEN DEVELOPED THAT CAN BE DOWNLOADABLE FROM THE WEBSITE AND DISTRIBUTED BY NURSES/PHYSICIAN ASSISTANTS AND OTHER HCPS. TOPICS INCLUDE THE GOALS OF THERAPY, THE SIDE EFFECTS OF THERAPIES, IMPORTANT POINTS/STRATEGIES AROUND ADHERENCE, AS WELL AS OTHER SUPPORTIVE RESOURCES, SUCH AS CALL-IN NUMBERS FOR FINANCIAL OR OTHER ASSISTANCE, ETC. SPECIFIC CONTENT ON TARGETED THERAPIES, IMMUNOTHERAPIES, COMBINATIONS, INTRALESIONAL IMMUNOTHERAPIES, AND THE ADJUVANT SETTING ARE INCLUDED.8. DEVELOPMENT OF PATIENT AND HCP VIDEOS HAVE BEEN DEVELOPED TO ADDRESS THE ISSUES OF PREVENTION AND EARLY DETECTION, SURGERY, PATHOLOGY, TREATMENT, SIDE EFFECTS AND MANAGMENET FOR BOTH TARGETED AND IMMUNOTHERAPIES, CLINICAL TRIALS, AND LIVING WITH MELANOMA. THE HCP VIDEOS WERE DEVELOPED TO ASSIST HCPS TO CARE FOR PATIENTS DURING COVID. THE VIDEOS ARE AVAILABLE ON AIM AT MELANOMA SITE'S YOUTUBE CHANNEL.9. AIM PROVIDED WEB BASED EDUCATION ON STRATEGIES TO SUPPORT SHARED DECISION MAKING IN THE STAGE IV SETTING. THE EDUCATION IS AVAILABLE AS WELL ON THE MNI WEBSITE.
IRS990/ProhibitedTaxShelterTransInd00
IRS990/PYBenefitsPaidToMembersAmt00
IRS990/PYContributionsGrantsAmt02730026
IRS990/PYExcessBenefitTransInd00
IRS990/PYGrantsAndSimilarPaidAmt0228200
IRS990/PYInvestmentIncomeAmt013358
IRS990/PYOtherExpensesAmt0806678
IRS990/PYOtherRevenueAmt098402
IRS990/PYProgramServiceRevenueAmt059471
IRS990/PYRevenuesLessExpensesAmt01059059
IRS990/PYSalariesCompEmpBnftPaidAmt0807320
IRS990/PYTotalExpensesAmt01842198
IRS990/PYTotalProfFndrsngExpnsAmt00
IRS990/PYTotalRevenueAmt02901257
IRS990/QuidProQuoContributionsInd00
IRS990/ReconcilationRevenueExpnssAmt0391573
IRS990/RegularMonitoringEnfrcInd00
IRS990/RelatedEntityInd00
IRS990/RelatedOrganizationCtrlEntInd00
IRS990/ReportInvestmentsOtherSecInd00
IRS990/ReportLandBuildingEquipmentInd01
IRS990/ReportOtherAssetsInd00
IRS990/ReportOtherLiabilitiesInd01
IRS990/ReportProgramRelatedInvstInd00
IRS990/RtnEarnEndowmentIncmOthFndsGrp/BOYAmt04681814
IRS990/RtnEarnEndowmentIncmOthFndsGrp/EOYAmt05073387
IRS990/SavingsAndTempCashInvstGrp/BOYAmt03815883
IRS990/SavingsAndTempCashInvstGrp/EOYAmt04277158
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt02571483
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt02730026
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt02133571
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt02552720
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus4YearsAmt02540964
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt012528764
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearAmt05328
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus1YearAmt013358
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus2YearsAmt033124
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus3YearsAmt018928
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus4YearsAmt03344
IRS990ScheduleA/GrossInvestmentIncome170Grp/TotalAmt074082
IRS990ScheduleA/OtherIncome170Grp/CurrentTaxYearAmt09500
IRS990ScheduleA/OtherIncome170Grp/CurrentTaxYearMinus1YearAmt0157873
IRS990ScheduleA/OtherIncome170Grp/CurrentTaxYearMinus2YearsAmt0168365
IRS990ScheduleA/OtherIncome170Grp/TotalAmt0335738
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportCY170Pct00.45670
IRS990ScheduleA/PublicSupportPY170Pct00.43960
IRS990ScheduleA/PublicSupportTotal170Amt05909154
IRS990ScheduleA/SubstantialContributorsTotAmt06619610
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY170Ind0X
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt02571483
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt02730026
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt02133571
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus3YearsAmt02552720
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus4YearsAmt02540964
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt012528764
IRS990ScheduleA/TotalSupportAmt012938584
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990/ScheduleBRequiredInd01
IRS990ScheduleD/ExpensesNotReportedAmt00
IRS990ScheduleD/ExpensesNotRptFinclStmtAmt00
IRS990ScheduleD/ExpensesSubtotalAmt02194738
IRS990ScheduleD/OtherLandBuildingsGrp/BookValueAmt017825
IRS990ScheduleD/OtherLandBuildingsGrp/DepreciationAmt065066
IRS990ScheduleD/OtherLandBuildingsGrp/OtherCostOrOtherBasisAmt082891
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Amt02962
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Amt15058
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Desc0PENSION PAYABLE
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Desc1INSURANCE PAYABLE
IRS990ScheduleD/OtherRevenuesNotIncludedAmt014828
IRS990ScheduleD/RevenueNotReportedAmt00
IRS990ScheduleD/RevenueNotReportedFinclStmtAmt014828
IRS990ScheduleD/RevenueSubtotalAmt02571483
IRS990ScheduleD/SupplementalInformationDetail/ExplanationTxt0INVESTMENT INCOME 5,328. CONSULTING AND HONORARIUM 9,500.
IRS990ScheduleD/SupplementalInformationDetail/FormAndLineReferenceDesc0PART XI, LINE 4B - OTHER ADJUSTMENTS:
IRS990ScheduleD/TotalBookValueLandBuildingsAmt017825
IRS990ScheduleD/TotalExpensesPerForm990Amt02194738
IRS990ScheduleD/TotalLiabilityAmt08020
IRS990ScheduleD/TotalRevenuePerForm990Amt02586311
IRS990ScheduleD/TotalRevEtcAuditedFinclStmtAmt02571483
IRS990ScheduleD/TotExpnsEtcAuditedFinclStmtAmt02194738
IRS990ScheduleG/FundraisingEventInformationGrp/Event1Nm0AIM FOR THE "CURE MELANOMA WALKS"
IRS990ScheduleG/FundraisingEventInformationGrp/GrossReceiptsEvent1Amt0342368
IRS990ScheduleG/FundraisingEventInformationGrp/GrossReceiptsTotalAmt0342368
IRS990ScheduleG/FundraisingEventInformationGrp/GrossRevenueEvent1Amt0342368
IRS990ScheduleG/FundraisingEventInformationGrp/GrossRevenueTotalEventsAmt0342368
IRS990ScheduleG/FundraisingEventInformationGrp/NetIncomeSummaryAmt0342368
IRS990ScheduleI/GrantRecordsMaintainedInd01
IRS990ScheduleI/RecipientTable/CashGrantAmt010000
IRS990ScheduleI/RecipientTable/CashGrantAmt138000
IRS990ScheduleI/RecipientTable/CashGrantAmt2200000
IRS990ScheduleI/RecipientTable/NonCashAssistanceAmt00
IRS990ScheduleI/RecipientTable/NonCashAssistanceAmt10
IRS990ScheduleI/RecipientTable/NonCashAssistanceAmt20
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt0CANCER AND MELANOMA RESEARCH
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt1CANCER AND MELANOMA RESEARCH
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt2TISSUE BANK
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt0OHSU KNIGHT CANCER INSTITUTE
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt1UPMC UNIV OF PITTSBURGH CANCER INSTITUTE
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt2MTBC MELANOMA TISSUE BANK CONSORTIUM
IRS990ScheduleI/RecipientTable/RecipientEIN0237083114
IRS990ScheduleI/RecipientTable/RecipientEIN1250965591
IRS990ScheduleI/RecipientTable/RecipientEIN2462454076
IRS990ScheduleI/RecipientTable/USAddress/AddressLine1Txt01121 SW SALMON STREET
IRS990ScheduleI/RecipientTable/USAddress/AddressLine1Txt15150 CENTRE AVENUE
IRS990ScheduleI/RecipientTable/USAddress/AddressLine1Txt21779 MARKHAM WAY
IRS990ScheduleI/RecipientTable/USAddress/CityNm0PORTLAND
IRS990ScheduleI/RecipientTable/USAddress/CityNm1PITTSBURGH
IRS990ScheduleI/RecipientTable/USAddress/CityNm2SACRAMENTO
IRS990ScheduleI/RecipientTable/USAddress/StateAbbreviationCd0OR
IRS990ScheduleI/RecipientTable/USAddress/StateAbbreviationCd1PA
IRS990ScheduleI/RecipientTable/USAddress/StateAbbreviationCd2CA
IRS990ScheduleI/RecipientTable/USAddress/ZIPCd097205
IRS990ScheduleI/RecipientTable/USAddress/ZIPCd115232
IRS990ScheduleI/RecipientTable/USAddress/ZIPCd295818
IRS990ScheduleJ/AnyNonFixedPaymentsInd00
IRS990ScheduleJ/BoardOrCommitteeApprovalInd0X
IRS990ScheduleJ/CompBasedOnRevenueOfFlngOrgInd00
IRS990ScheduleJ/CompBsdNetEarnsFlngOrgInd00
IRS990ScheduleJ/CompBsdNetEarnsRltdOrgsInd00
IRS990ScheduleJ/CompBsdOnRevRelatedOrgsInd00
IRS990ScheduleJ/EquityBasedCompArrngmInd00
IRS990ScheduleJ/Form990OfOtherOrganizationsInd0X
IRS990ScheduleJ/InitialContractExceptionInd00
IRS990/ScheduleJRequiredInd01
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/BaseCompensationFilingOrgAmt0162000
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/BaseCompensationFilingOrgAmt1160008
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/BonusFilingOrganizationAmount025000
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/BonusFilingOrganizationAmount10
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/BonusRelatedOrganizationsAmt00
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/BonusRelatedOrganizationsAmt10
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/CompensationBasedOnRltdOrgsAmt00
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/CompensationBasedOnRltdOrgsAmt10
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/CompReportPrior990FilingOrgAmt00
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/CompReportPrior990FilingOrgAmt10
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/CompReportPrior990RltdOrgsAmt00
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/CompReportPrior990RltdOrgsAmt10
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/DeferredCompensationFlngOrgAmt00
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/DeferredCompensationFlngOrgAmt10
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/DeferredCompRltdOrgsAmt00
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/DeferredCompRltdOrgsAmt10
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/NontaxableBenefitsFilingOrgAmt022963
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/NontaxableBenefitsFilingOrgAmt10
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/NontaxableBenefitsRltdOrgsAmt00
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/NontaxableBenefitsRltdOrgsAmt10
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/OtherCompensationFilingOrgAmt00
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/OtherCompensationFilingOrgAmt10
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/OtherCompensationRltdOrgsAmt00
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/OtherCompensationRltdOrgsAmt10
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/PersonNm0SAMANTHA GUILD
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/PersonNm1ALICIA ROWELL
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/TitleTxt0PRESIDENT AND DIRECTOR
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/TitleTxt1VICE PRESIDENT
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/TotalCompensationFilingOrgAmt0209963
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/TotalCompensationFilingOrgAmt1160008
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/TotalCompensationRltdOrgsAmt00
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/TotalCompensationRltdOrgsAmt10
IRS990ScheduleJ/SeverancePaymentInd00

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2022 • Form 990Detailed filing. Detailed filing data is available for this year.

Open filing
Assets
$5,081,407
Liabilities
$8,020
Net assets
$5,073,387
Revenue
$2,586,311
Expenses
$2,194,738
Net income
$391,573
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024Detailed filing. Detailed filing data is available for this year.$6.67$0.02$6.65$2.97$2.33$0.64
2023Detailed filing. Detailed filing data is available for this year.$6.02$0.02$6.01$3.25$2.31$0.93
2022Detailed filing. Detailed filing data is available for this year.$5.08$0.01$5.07$2.59$2.19$0.39
2021Detailed filing. Detailed filing data is available for this year.$4.69$0.01$4.68$2.90$1.84$1.06
2020Detailed filing. Detailed filing data is available for this year.$3.67$0.05$3.62$2.34$1.82$0.52
2019Detailed filing. Detailed filing data is available for this year.$3.23$0.12$3.11$2.57$2.04$0.53
2018Detailed filing. Detailed filing data is available for this year.$2.57$0.00$2.57$2.54$2.37$0.17
2017Detailed filing. Detailed filing data is available for this year.$2.40$0.00$2.40$2.42$2.07$0.34
2016Detailed filing. Detailed filing data is available for this year.$2.05$0.00$2.05$1.78$1.41$0.37
2015Detailed filing. Detailed filing data is available for this year.$1.68$0.00$1.68$1.65$1.27$0.38
2014Detailed filing. Detailed filing data is available for this year.$1.30$0.00$1.30$1.32$1.20$0.12
2013Detailed filing. Detailed filing data is available for this year.$1.18$0.00$1.18$1.24$1.18$0.06
2012Facts available. Structured filing facts are available, but richer extracted sections are limited.$1.12$0.00$1.12$0.87
2011Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.84$0.00$0.83$0.87
2010Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.46$0.00$0.46$0.75